Tatjana Weil
- Co-authors
- Jan MünchJanis A. MüllerCarina ConzelmannDesirée SchützSteffen StengerRüdiger GroßLukas WettsteinJana Krüger
- Topics
- SARS-CoV-2 and COVID-19 Research (8 papers)COVID-19 Clinical Research Studies (5 papers)Pancreatic function and diabetes (2 papers)
- Partner nations
- GermanyNetherlandsDenmark
In The Last Decade
Tatjana Weil
14 papers receiving 251 citations
Peers
Comparison fields: 5 of 68
- Infectious Diseases 115
- Molecular Biology 82
- Epidemiology 29
- Biomedical Engineering 28
- Genetics 25
Countries citing papers authored by Tatjana Weil
This map shows the geographic impact of Tatjana Weil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatjana Weil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatjana Weil more than expected).
Fields of papers citing papers by Tatjana Weil
This network shows the impact of papers produced by Tatjana Weil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatjana Weil. The network helps show where Tatjana Weil may publish in the future.
Co-authorship network of co-authors of Tatjana Weil
This figure shows the co-authorship network connecting the top 25 collaborators of Tatjana Weil. A scholar is included among the top collaborators of Tatjana Weil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatjana Weil. Tatjana Weil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 2 | |
| 3 | 15 | |
| 4 | 14 | |
| 5 | 17 | |
| 6 | 18 | |
| 7 | 11 | |
| 8 | 13 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 0 | |
| 12 | 9 | |
| 13 | 46 | |
| 14 | 73 | |
| 15 | 25 |
About Tatjana Weil
Tatjana Weil is a scholar working on Infectious Diseases, Modeling and Simulation and Immunology, having authored 15 papers that have together received 256 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (5 papers) and Pancreatic function and diabetes (2 papers). The work is most often cited by research in Infectious Diseases (115 citations), General Dentistry (6 citations) and Aquatic Science (15 citations). Tatjana Weil has collaborated with scholars based in Germany, Netherlands and Denmark. Frequent co-authors include Jan Münch, Janis A. Müller, Carina Conzelmann, Desirée Schütz, Steffen Stenger, Rüdiger Groß, Lukas Wettstein, Jana Krüger, Lennart Koepke and Alexander Kleger. Their work appears in journals such as Clinical Infectious Diseases, Pharmacological Reviews and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.